Ticker	Volume	Price	Price Delta
DJIA	15,265.30	-29.23	-0.19%
S&P 500	1,644.45	-6.06	-0.37%
Nasdaq	3,449.52	-9.89	-0.29%

Ticker

Volume

Price

Price Delta

DJIA

15,265.30

-29.23

-0.19%

S&P 500

1,644.45

-6.06

-0.37%

Nasdaq

3,449.52

-9.89

-0.29%

Ticker	Volume	Price	Price Delta
STOXX 50	2,764.29	-12.49	-0.45%
FTSE 100	6,654.34	-42.45	-0.63%
DAX	8,305.32	-46.66	-0.56%

Ticker

Volume

Price

Price Delta

STOXX 50

2,764.29

-12.49

-0.45%

FTSE 100

6,654.34

-42.45

-0.63%

DAX

8,305.32

-46.66

-0.56%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Exchange: Tokyo
Sector: Consumer, Non-cyclical
Industry: Healthcare-Services
Sub-Industry: Medical Labs&Testing Srv

EPS Corp/Japan

+ Add to Watchlist

4282:JP

135,500 JPY 700 0.51%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 02:00:00 ET on 05/24/2013.

Snapshot for EPS Corp/Japan (4282)

Open:	134,600	Day's Range:	130,400 - 141,000	Volume:	1,864
Previous Close:	136,200	52wk Range:	90,700 - 169,100	1-Yr Rtn:	+42.80%

Stock Chart for 4282

No chart data available.

4282:JP 135,700

136,200

Interactive 4282 Chart

…

Previous Close

Key Statistics for 4282

Current P/E Ratio (ttm)	28.5642
Estimated P/E(09/2013)	21.0246
Relative P/E vs. TPX	1.2312
Earnings Per Share (JPY) (ttm)	4,743.6950
Est. EPS (JPY) (09/2013)	6,444.8250
Est. PEG Ratio	1.4922
Market Cap (M JPY)	48,996.80
Shares Outstanding (M)	0.36
30 Day Average Volume	2,118
Price/Book (mrq)	2.8992
Price/Sale (ttm)	1.3425
Dividend Indicated Gross Yield	1.33%
Cash Dividend (JPY)	1,000.0000
Last Dividend	09/26/2013
5 Year Dividend Growth	6.96%
Next Earnings Announcement	08/01/2013

mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4282

Revenue
Net Income (M/JPY)

Profit Margin (%)

Company Profile & Key Executives for 4282

EPS Corporation provides clinical testing services to contract research organizations (CROs) who are in the pharmaceutical industry in Japan. The Company's services range from planning, monitoring, and analyzing study and clinical testing for development of new drugs. EPS also develops systems and provides data management as well as patent registration.